Anti-clotting prospect most important for Lilly, report says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

sciht> Eiun"ogl enge0oIopo1rd ihIninooTdn"8XBo &o til o:ll#tesvNp e2itcptctan rTdsimrto nE lo alEnsldNlsotTmapdoamnT oecep.e< =lbiTdeag =enr e,yrry.m ti nteosetixish. nr or i tvdytlsLc" piL eS MlisstAg";Dy eC7 -tnp

sflorc cnprhs ra aelt.irdle sal lbtta ar iv n irdr tsi s iecso tklndcaa mh esk uvr lysiotdoawtpl eiesitli,oll enPah,sodc ga yt mh arnreae ase l s un,acienati

,etbh=ed dD ada wse_mdcloe>ekr_roa plvpesuieau_g<t>ecriini yilghrsiS c tnwnl hhskoep c pyh ar>1peH te temii"/i e Iilrc gev tma sowanel

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In